Amy Welsh
Corporate Officer/Principal at AGILE THERAPEUTICS, INC.
Net worth: 5 400 $ as of 2024-04-29
Amy Welsh active positions
| Companies | Position | Start | End |
|---|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 2022-10-31 | - |
| Sales & Marketing | 2020-04-30 | 2022-10-31 |
Career history of Amy Welsh
Former positions of Amy Welsh
| Companies | Position | Start | End |
|---|---|---|---|
| ANTARES PHARMA, INC. | Sales & Marketing | 2017-05-31 | 2020-04-30 |
Training of Amy Welsh
| LaSalle University | Undergraduate Degree |
Statistics
International
| United States | 4 |
Operational
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
- Stock Market
- Insiders
- Amy Welsh
- Experience
